KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2022
2021
2019
Related Segments
Underpayment Recovery Services 2024
Which Firms Drive Value in Both Recovery & Prevention?
Author
Mollie Hunt
Author
Alex McIntosh
Author
Shawn Howell
Amid continuing financial pressures to increase revenue with fewer resources, many provider organizations look to firms that can not only recover underpayments but also help improve internal processes to prevent future revenue leakage. Since the 2022 report on underpayment recovery services, KLAS has broken out a denials management services market segment (reported on earlier this year); now, underpayment recovery services include charge capture, transfer DRG, DRG validation, and zero-balance review. Additionally, there have been several acquisitions that have affected the market (i.e., the R1 RCM acquisition of Cloudmed, the FinThrive acquisition of TransUnion Healthcare). This report explores what service lines organizations use firms for, how well firms provide actionable insights, how firms help organizations prevent future revenue leakage, and what factors drive firm selection across the market.
If you don't have a login, getting started is easy.
Key Findings
- Customers Use R1 RCM Widely across Service Lines, See Firm as a Strong Partner
- BESLER Seen as an Expert in Transfer DRG, Provides an Easy Engagement for Customers
- Revecore Customers Highlight Responsive Support; Some Seeking More Actionable Insights
- Across Market, Value Is Most Top of Mind when Choosing Firm
Writer
Carlisa Cramer
Designer
Kath Spencer
Project Manager
Sydney Toomer
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.